TCL Archive EPO Controversy: ODAC To Review EPO Agents in May; SEC Probes Amgen’s Delay in Study Disclosure. March 2, 2007
TCL Archive Hyperthermia Offers Prospects For Major Treatment Advance, Investigators Says March 11, 1977
TCL Archive NCI, FDA, Correlogic To Begin Large Trial Of Protein Pattern Diagnostic System for Ovarian Cancer June 28, 2002